about
Antiviral activity of the oseltamivir and Melissa officinalis L. essential oil against avian influenza A virus (H9N2).Antimicrobial and Cytotoxic Activity of Cuminum Cyminum as an Intracanal Medicament Compared to Chlorhexidine Gel.Stereological investigation of the effect of Elaeagnus angustifolia fruit hydroalcoholic extract on osteoporosis in ovariectomized rats.Hydroalcoholic extract of Carum carvi L. in oral mucositis: a clinical trial in male golden hamsters.Time-dependent antibacterial effects of Aloe vera and Zataria multiflora plant essential oils compared to calcium hydroxide in teeth infected with Enterococcus faecalis.Biochemical, hematological, and pathological related healing effects of Elaeagnus angustifolia hydroalcoholic extract in 5-fluorouracil-induced oral mucositis in male golden hamster.Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease.The Protective Effect of Hydroalcoholic Extract of Zingiber officinale Roscoe (Ginger) on Ethanol-Induced Reproductive Toxicity in Male Rats.Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis.N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological EvaluationInhibition of LPS-induced inflammatory responses by Satureja hortensis extracts in J774.1 macrophagesOne-pot synthesis of thioxo-tetrahydropyrimidine derivatives as potent β-glucuronidase inhibitor, biological evaluation, molecular docking and molecular dynamics studiesNovel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligandsMulti-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1,2,4-triazine scaffold containing pendant phenoxy methyl-1,2,3-triazole: Design, synthesis and biological evaluationTetrahydroquinolinone derivatives as potent P-glycoprotein inhibitors: design, synthesis, biological evaluation and molecular docking analysisSynthesis of novel sepiolite-iron oxide-manganese dioxide nanocomposite and application for lead(II) removal from aqueous solutions5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer's disease modifying agentsStructure-Based Design, Synthesis, Biological Evaluation and Molecular Docking Study of 4-Hydroxy-N'-methylenebenzohydrazide Derivatives Acting as Tyrosinase Inhibitors as Potentiate Anti-Melanogenesis ActivitiesEffects of Citrullus colocynthis L. in a rat model of diabetic neuropathyEfficacy of Anise (Pimpinella anisum L.) oil for migraine headache: A pilot randomized placebo-controlled clinical trialEfficacy of black seed (Nigella sativa L.) on kidney stone dissolution: A randomized, double-blind, placebo-controlled, clinical trialEfficacy of inhaled Lavandula angustifolia Mill. Essential oil on sleep quality, quality of life and metabolic control in patients with diabetes mellitus type II and insomniaProtection by pure and genistein fortified extra virgin olive oil, canola oil, and rice bran oil against acetic acid-induced ulcerative colitis in ratsDesign and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine DerivativesExopolysaccharide from Pantoea sp. BCCS 001 GH isolated from nectarine fruit: production in submerged culture and preliminary physicochemical characterizationsScreening the antifungal activities of monoterpenes and their isomers against Candida species New insights into antifungal activity of essential oils components
P50
Q40629024-C8D33681-5F5F-404D-85CC-EE2249688E3AQ40806031-4FA19307-9457-4BE7-BBC7-66D9A70B9736Q41025098-C056B4E1-17BC-4C3A-AAC3-0ACDBA2D25B9Q41312854-91B53630-E74D-4593-B220-040B02C6354BQ41754864-25EB006F-4845-4763-9766-FB58534FE7A8Q47253675-007900EB-953D-4660-A8AC-BA6184DD2849Q47436561-10C07D28-5B3A-4192-A135-73D651CFC48CQ49926935-6FE4833D-87DA-42FB-9BF5-5851E6F42EAFQ50879807-F847FDAF-B2B9-4BAF-B8FC-649E712113AEQ86954750-BB467AF2-E310-4538-A875-FBA5D48C8C7CQ89137967-5BED91B9-2C4E-47DA-A176-461143C529A5Q89881226-253DD234-8FB0-4A07-A6AB-71C11D82C95DQ89893474-57685696-9FF4-448E-9030-3921D6723D51Q90361650-1B9D4357-2271-4730-AEFE-6B30B59472EEQ90949162-10482EBC-343B-47F0-A50A-9EB1D68C76C9Q91935328-C35A20F6-B581-4AD3-B88C-39C6EE49E427Q92052270-6BC79CD7-FC8E-4DB5-814B-3A3A5A3A4D25Q92142375-A5FBD060-BA51-48C0-AB2D-8C68696AD43BQ92238078-99847C45-9C2C-45DA-8955-6D3416FBC4ADQ92253841-BE6B2853-7ED2-4FD2-8914-B2A65CA7313BQ92378838-D2063096-35FB-4A82-A56B-7CE6A4B12F63Q92601159-C3298BFF-E593-4290-A697-68DE3FB86F3DQ92672111-31E500C7-5E1E-41C7-A0B1-1F7D08DA3A60Q93261678-14C68FF9-577C-40DD-8392-3F2242EDD149Q93354483-1FEBA1C7-E1BD-41D3-8626-8451F7F3AA89Q96163108-33A177A6-40CF-4179-B0F5-097C670E3687
P50
description
investigador
@es
researcher
@en
name
A Iraji
@en
type
label
A Iraji
@en
prefLabel
A Iraji
@en
P31
P496
0000-0002-8442-2205